FilingSEC EDGAR8-K
Iridex Reports Q2 2026 Revenue of $12.6 Million and Net Loss of $1.3 Million
· SEC accepted
StageEarnings Release
Filing content
Iridex reported second-quarter revenue of $12.6 million, a 7% decline year-over-year, and a net loss of $1.3 million, despite growth in its glaucoma business.
AI summary of the filing. Please also check the source.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…